ATE218366T1 - Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung - Google Patents
Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilungInfo
- Publication number
- ATE218366T1 ATE218366T1 AT99940446T AT99940446T ATE218366T1 AT E218366 T1 ATE218366 T1 AT E218366T1 AT 99940446 T AT99940446 T AT 99940446T AT 99940446 T AT99940446 T AT 99940446T AT E218366 T1 ATE218366 T1 AT E218366T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- composition containing
- factor xiiia
- containing factor
- nerve healing
- Prior art date
Links
- 230000035876 healing Effects 0.000 title abstract 2
- 210000005036 nerve Anatomy 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108010000196 Factor XIIIa Proteins 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12598398A IL125983A0 (en) | 1998-08-30 | 1998-08-30 | Pharmaceutical composition comprising factor xiiia |
| PCT/IL1999/000472 WO2000012119A2 (en) | 1998-08-30 | 1999-08-30 | PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218366T1 true ATE218366T1 (de) | 2002-06-15 |
Family
ID=11071906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99940446T ATE218366T1 (de) | 1998-08-30 | 1999-08-30 | Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1109573B1 (de) |
| JP (1) | JP2002523467A (de) |
| AT (1) | ATE218366T1 (de) |
| AU (1) | AU5441999A (de) |
| CA (1) | CA2341499A1 (de) |
| DE (1) | DE69901716T2 (de) |
| IL (1) | IL125983A0 (de) |
| WO (1) | WO2000012119A2 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1084888A (zh) * | 1992-07-30 | 1994-04-06 | 耶达研究及发展有限公司 | 由酶促反应制备的二聚il-2以及用于制备该il-2的源于神经的转谷氨酰胺酶 |
| EP0691850B1 (de) * | 1993-03-30 | 2002-09-25 | Hoechst Japan Limited | Faktor XIII zur Behandlung von Hautwunden |
| US5800812A (en) * | 1995-09-15 | 1998-09-01 | Yeda Research And Development Co. Ltd. | Methods of use of mononuclear phagocytes to promote axonal regeneration |
-
1998
- 1998-08-30 IL IL12598398A patent/IL125983A0/xx unknown
-
1999
- 1999-08-30 EP EP99940446A patent/EP1109573B1/de not_active Expired - Lifetime
- 1999-08-30 CA CA002341499A patent/CA2341499A1/en not_active Abandoned
- 1999-08-30 AU AU54419/99A patent/AU5441999A/en not_active Abandoned
- 1999-08-30 AT AT99940446T patent/ATE218366T1/de not_active IP Right Cessation
- 1999-08-30 DE DE69901716T patent/DE69901716T2/de not_active Expired - Fee Related
- 1999-08-30 WO PCT/IL1999/000472 patent/WO2000012119A2/en not_active Ceased
- 1999-08-30 JP JP2000567233A patent/JP2002523467A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2341499A1 (en) | 2000-03-09 |
| IL125983A0 (en) | 1999-04-11 |
| EP1109573A2 (de) | 2001-06-27 |
| DE69901716D1 (de) | 2002-07-11 |
| JP2002523467A (ja) | 2002-07-30 |
| WO2000012119A2 (en) | 2000-03-09 |
| AU5441999A (en) | 2000-03-21 |
| WO2000012119A3 (en) | 2000-06-02 |
| EP1109573B1 (de) | 2002-06-05 |
| DE69901716T2 (de) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
| BR0015188A (pt) | Composições farmacêuticas | |
| CY1118206T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη | |
| DK0740650T3 (da) | Codrugs som metode til styret transport af lægemiddel | |
| BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
| SE9504661D0 (sv) | New compounds | |
| BR9711805A (pt) | Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos | |
| GT199700009AA (es) | Terapia combinada para la osteoporosis | |
| AR035348A1 (es) | Indoles sustituidos, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos en la preparacion de medicamentos | |
| DK1079807T3 (da) | Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje | |
| PT754176E (pt) | Novos carbamatos e ureias como modificadores da resistencia a multiplas drogas | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| BR0008509A (pt) | Composição farmacêutica oral estabilizada contendo iodeto e iodato e método | |
| SE9802208D0 (sv) | Novel compounds | |
| BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
| BR0211932A (pt) | Métodos e composições para administração oral de hormÈnio de paratireóide, pth | |
| BR9811298A (pt) | Uso de um composto de vanádio fisiologicamente aceitável | |
| ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
| ATE280588T1 (de) | Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren | |
| SE9802209D0 (sv) | Novel compounds | |
| DE59914183D1 (de) | Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| SE9504662D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |